7 April 2016 - The TGA registered three new medicines and one new combination product in March 2016: lumacaftor with ivacaftor (Orkambi), selexipag (Uptravi), panobinostat lactate (Farydak) and ceritinib (Zykadia).

View the full article on the TGA website.

Related MAESTrO database links

• Entry for Orkambi
• Entries for Uptravi
• Entry for Farydak
• Entry for Zykadia